Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinidine versus verapamil in short-coupled idiopathic ventricular fibrillation
2021-005688-36Phase 2Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of quinidine and verapamil in idiopathic ventricular fibrillation (IVF) and polymorphic ventricular tachycardia (PVT) (2 arms), sponsored by Amsterdam University Medical Center. Started Aug 2022; status: active.
02
Drugs
quinidineverapamil
03
Conditions
idiopathic ventricular fibrillation (IVF)polymorphic ventricular tachycardia (PVT)
Beyond the preview
Go deeper on 2021-005688-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005688-36.